Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages

  Ortholan, Cécile ^a,b   Romestaing, Pascale ^c   Chapet, Olivier ^d   Gerard, Jean Pierre ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CENTRE HOSPITALIER PRINCESSE GRACE   (Monaco)

^c Hopital Prive Jean Mermoz   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Conservative treatment; Contact radiotherapy; Neoadjuvant treatment; Randomized trial; Rectal cancer

Indexed keywords

CLINICAL RESPONSE; CONSERVATIVE TREATMENTS; DISEASE FREE SURVIVAL; DOSE ESCALATION; EXTERNAL BEAM RADIOTHERAPY; LOCAL RECURRENCE; NEOADJUVANT RADIATION; NEOADJUVANT RADIOTHERAPY; NEOADJUVANT TREATMENT; ORGAN PRESERVATION; OVERALL SURVIVAL; RANDOMIZED TRIAL; RECTAL CANCER; TUMOR RESPONSE;

DISEASES;

RADIOTHERAPY;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLOSTOMY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; SPHINCTER; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; BRACHYTHERAPY; COLOSTOMY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGAN SPARING TREATMENTS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; REMISSION INDUCTION;

EID: 84861045125     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.002     Document Type: Article

References (19)

1. R.J. Heald, B.J. Moran, and R.D. Ryall Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997 Arch Surg 133 1998 894 899 (Pubitemid 28374285)
2. K.C. Peeters, C.A. Marijnen, I.D. Nagtegaal Dutch Colorectal Cancer Group The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 2007 693 701 (Pubitemid 350035641)
3. R. Sauer, H. Becker, and W. Hohenberger Preoperative vs. postoperative radiochemotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
4. D. Sebag-Montefiore, R.J. Stephens, and R. Steele Preoperative radiotherapy vs. selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial Lancet 373 2009 811 820
5. Y. Francois, C.J. Nemoz, and J. Baulieux Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial J Clin Oncol 17 1999 2396 2402 (Pubitemid 29368238)
6. J.F. Bosset, L. Collette, G. Calais EORTC Radiotherapy Group Trial 22921 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123 (Pubitemid 44394918)
7. J.P. Gérard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 2006 4620 4625 (Pubitemid 46630960)
8. J. Papillon Present status of radiation therapy in the conservative management of rectal cancer Radiother Oncol 17 1990 275 283 (Pubitemid 20130036)
9. J.P. Gerard, O. Chapet, and A. Ramaioli Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone Int J Radiat Oncol Biol Phys 54 2002 142 149
10. J.P. Gerard, O. Chapet, and C. Nemoz Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial J Clin Oncol 22 2004 2404 2409 (Pubitemid 41115397)
11. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346 (Pubitemid 26342716)
12. K. Bujko, L. Kepka, and W. Michalski Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials Radiother Oncol 80 2006 4 12
13. J.P. Gérard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 2010 1638 1644
14. C. Aschele, C. Pinto, and S. Cordio Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial ASCO Meeting Abstracts 27 2009 CRA4008
15. S. Ngan, R. Fisher, and D. Goldstein A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS) ASCO Meeting Abstracts 28 2010 3509
16. C. Ortholan, E. Francois, and O. Thomas Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: Evidence from randomized trials Dis Colon Rectum 49 2006 302-130
17. G. Lezoche, M. Baldarelli, and M. Guerrieri A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy Surg Endosc 22 2008 352 358
18. A. Habr-Gama, R.O. Perez, and I. Proscurshim Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy J Gastrointest Surg 10 2006 1319 1328
19. A. Habr-Gama, R.O. Perez, and J. Sabbaga Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: Results of a prospective study using additional chemotherapy during the resting period Dis Colon Rectum 52 2009 1927 1934